The @US_FDA approved Xocova (ensitrelvir) oral tablets for postexposure prophylaxis of #COVID‑19 in adults and adolescent patients 12 years and older following contact with an individual who has COVID-19. 💊ow.ly/ww5V50Zb6RB 💊ow.ly/7uuj50Zb6RE #DrugNews #Pharmacy

AI guardrails monitor behavior, but trustworthy outputs require deep clinical knowledge. See how it works in our latest whitepaper with @FierceHealthcare ow.ly/hgxg50Z4Y5s

Building AI gets the headlines. Implementing it safely in healthcare is the real work. Join us at HLTH Europe 2026 for the Startup Stage panel: From the Ritz to the Rubble: Why implementation is the real work in AI. •Tuesday, 16 June •9:00–9:40 AM •Startup Stage Hear from a panel of healthcare and AI leaders, including Sheila Bond, MD, Director, Clinical Content Strategy, Wolters Kluwer Health, on what it takes to deploy AI responsibly, from trusted clinical content to governance at scale. Learn more: ow.ly/nKgO50Z8UVv #HLTHEurope2026 #AIinHealthcare #HealthTech

For children with septic shock, BCS (e.g., lactated Ringer's) and NS show similar 30-day outcomes (death, renal therapy, kidney dysfunction). NS caused more hyperchloremia/hypernatremia; BCS increased lactate. Both are viable options. Stay #UpToDate with What’s New in What’s New in #EmergencyMedicine: ow.ly/AtEZ50Z01Yk #ClinicalUpdates #MedTwitter

Clinicians and patients are both reaching for AI, but for different reasons. Clinicians want relief from admin burden, with 79% citing tasks like prior authorizations as a top challenge. Patients want speed and clarity, using AI to research side effects (54%) and understand their diagnoses (52%). Same goal. Different paths. A big opportunity for the leaders who can align them. Get insights from the 2026 Future Ready Healthcare Survey Report: ow.ly/qTKQ50Z9wB8 #ClinicalAI #HealthcareAI #DigitalHealth

Clinical decisions impact lives. That’s why AI validation for care settings can’t stop at benchmark performance. Clinical and product teams need a multidimensional framework to assess AI responses across three dimensions: •Clinical intent •Knowledge integrity •Potential risks This approach brings AI evaluation closer to the realities of point-of-care use, where accuracy, relevance, and safety all matter. Read the white paper:
ow.ly/m71v50Z6G9a #ClinicalAI #ClinicalDecisionSupport #AIValidation

🧠 It's Clinical Challenge time! True or false? Midline catheters (MCs) confer a lower risk of upper extremity deep venous thrombosis than peripherally inserted central catheters. Reply with your response 👇 #Surgery #ClinicalChallenge #UpToDate

Join us at ASHP Pharmacy Futures June 13-17 in St. Louis to explore how UpToDate® and UpToDate® Lexidrug™ can empower your team with AI-driven solutions. Book a meeting today and unlock the future of pharmacy. ow.ly/h2yn50Z7RkA

AI decisions made today will shape the future of care. At #HLTHEurope, we’ll be exploring how healthcare organisations can make more confident, informed choices from the start. Book a meeting with us at HLTH Europe: ow.ly/aSKO50Z1PcC

The @US_FDA has approved Accord BioPharma’s Ennumo (pegfilgrastim-pccg) subcutaneous injection as a biosimilar to Neulasta (pegfilgrastim). Check out our drug referential resources: 💊ow.ly/LfRQ50Z4RZT 💊ow.ly/ULF250Z4RZU #DrugNews #Pharmacy #Medication

This Healthcare Executives Appreciation Week, we extend our deepest gratitude to the leaders who drive progress in healthcare. Join us in celebrating these incredible leaders. Share your appreciation for a healthcare executive who has made a difference in your organization in the comments below. #HealthcareLeadership #PatientCare #HealthcareExecutives #UpToDateSupportsHealth

AI use in healthcare is growing at a breakneck pace. In just one year, the share of doctors using AI multiple times a day more than tripled, and nurses' multiple-daily use doubled. The momentum reaches patients too: 7 in 10 now use AI every week. The new 2026 Future Ready Healthcare Survey Report shows what this shift means for clinicians, patients, and the leaders connecting them. Explore the insights: ow.ly/tNfo50Z7Rk3

Q: How do you scale trust in AI development? A: True medication intelligence goes beyond clinical facts to support responsible AI decision-making. Check out the new whitepaper to find out how. ow.ly/9Tcw50Z4Y1z

Left bundle branch pacing (LBBP) reduces pacing-induced cardiomyopathy (6.5% vs 18.2%) and improves NYHA functional class compared to RV pacing in patients with high pacing burden. Stay #UpToDate with What’s New in #CardiovascularMedicine: ow.ly/NXHR50Z01PA #ClinicalUpdates #MedTwitter

💰 Health Tech ROI: Financial Impact Agentic AI is powerful but costly—so use it wisely. Focus on solutions that grow panel sizes, improve care coordination, and reduce total medical spend. 💡 The result? Tens of thousands—or even millions—in ROI. Invest in tech that drives real, measurable value. ow.ly/W0Z450YnRI3 #DigitalHealthTech #ClinicalWorkflows #ProductsStrategy #TechDevelopers #HealthcareInnovation #UpToDateConnect

Shadow AI governance starts with awareness. When employees don’t know which AI tools are approved, governance gets harder, and risk grows. In an Expert Insight, Wolters Kluwer Health CMO, Dr. Peter Bonis, explained why healthcare leaders should treat shadow AI as feedback, not misconduct, and why less-resourced organizations may face added challenges in adopting and governing AI safely. Read the article and watch the full webinar from Becker's Healthcare: ow.ly/4GCM50Z4rWQ #HealthcareAI #HealthIT #DigitalHealth #ClinicalLeadership

🧠 It's Clinical Challenge time! True or false? In children <2 years old, low-weight-for-age is diagnostic of weight faltering (poor weight gain). Provide your answers in the comments. #Pediatrics #ClinicalChallenge

Medication intelligence can’t rely on AI alone. It needs clinician-led development, reliable and explainable outputs, and trusted content at the core. In Becker’s Hospital Review, Staci A. Hermann, PharmD, MS, FASHP, FACHE, Vice President, Embedded Clinical Decision Support Content, shares why expert AI matters for safer, smarter medication decisions. Read the article: ow.ly/vRwG50Z4YsR #MedicationIntelligence #HealthcareAI #ClinicalDecisionSupport #PharmacyLeadership

The @US_FDA approved Baxfendy (baxdrostat) oral tablets, in combination with other antihypertensive medications, for treatment of hypertension in adults who are not adequately controlled on other medications. 💊ow.ly/YVGN50Z4Qn4 💊ow.ly/38Sw50Z4Qn5 #DrugNews

Medication intelligence is key to scaling health tech and AI readiness. Find out why in our new whitepaper. #AI ow.ly/t62r50Z4XWS